Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

Clin Transl Med. 2022 Jan;12(1):e704. doi: 10.1002/ctm2.704.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alpha-Globulins / metabolism*
  • Biomarkers / metabolism
  • COVID-19 / metabolism*
  • COVID-19 / therapy
  • COVID-19 / virology
  • Cholesterol Esters / metabolism*
  • Glutamic Acid / metabolism*
  • Humans
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Alpha-Globulins
  • Biomarkers
  • Cholesterol Esters
  • inter-alpha-inhibitor
  • Glutamic Acid